Literature DB >> 11319807

Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping.

G Rigaud1, P S Moore, D Taruscio, M Scardoni, M Montresor, F Menestrina, A Scarpa.   

Abstract

Five cases of primary mediastinal B-cell lymphoma (PMBL) each have been studied with 375 microsatellite markers from all 22 autosomes. Of the 151 genomic alterations among the 1,875 assays, only five were allelic losses. The remainder of the microsatellite alterations consisted of 114 allelic imbalances and 32 instabilities. Microsatellite alterations were found in all cases on chromosomal arms 6p and 9p. These allelic imbalances most likely are indicative of genetic amplification, a finding agreeing well with those of studies using either comparative genomic hybridization or arbitrarily primed polymerase chain reaction, in which amplification of chromosome arm 9p in PMBL has been found. The allelic imbalances on chromosome arm 6p always included marker D6S276 located at 6p21.3-p22.3, where the MHC class I genes reside. These allelic imbalances may be reflective of alterations in the expression of the MHC gene products, characteristic of PMBL. Allelic anomalies close to the MYB gene locus on 6q were detected in two cases and prompted the analysis of MYB rearrangements in a series of 30 lymphomas. One rearrangement was detected in one of 18 cases of PMBL and in none of 10 diffuse, large B-cell lymphomas and two T-cell lymphomas. Our genome-wide microsatellite analysis provides independent confirmation that PMBL is characterized by infrequent chromosomal losses and by frequent genetic alterations involving chromosomal arm 9p. For the first time, chromosomal arm 6p has been identified as a highly frequent target of genetic alterations in this tumor type. Finally, MYB may also be involved occasionally in PMBL pathogenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11319807     DOI: 10.1002/gcc.1133

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  [Mediastinal large B-cell lymphoma].

Authors:  T F E Barth; P Möller
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

Review 2.  Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies.

Authors:  Kieron Dunleavy
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH.

Authors:  Cherie H Dunphy; Dennis P O'Malley; Liang Cheng; Tina Y Fodrie; Sherrie L Perkins; Kathleen Kaiser-Rogers
Journal:  J Hematop       Date:  2008-06-18       Impact factor: 0.196

4.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 5.  Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

Authors:  Amit Dipak Amin; Tara L Peters; Lingxiao Li; Soumya Sundara Rajan; Ramesh Choudhari; Soham D Puvvada; Jonathan H Schatz
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-05

Review 6.  AYA Considerations for Aggressive Lymphomas.

Authors:  Gabriela Llaurador; Lisa Giulino-Roth
Journal:  Curr Hematol Malig Rep       Date:  2021-03-16       Impact factor: 3.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.